115 related articles for article (PubMed ID: 28643743)
1. Dual association of serum interleukin-10 levels with colorectal cancer.
Abtahi S; Davani F; Mojtahedi Z; Hosseini SV; Bananzadeh A; Ghaderi A
J Cancer Res Ther; 2017; 13(2):252-256. PubMed ID: 28643743
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
Wang P; Li C; Ma X; Gai X
Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
[TBL] [Abstract][Full Text] [Related]
3. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
[TBL] [Abstract][Full Text] [Related]
6. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.
Gao LB; Rao L; Wang YY; Liang WB; Li C; Xue H; Zhou B; Sun H; Li Y; Lv ML; Du XJ; Zhang L
Carcinogenesis; 2009 Feb; 30(2):295-9. PubMed ID: 19073878
[TBL] [Abstract][Full Text] [Related]
7. [Role of IL-12P40 and IL-10 in progression of colorectal cancer].
Stanilov N; Miteva L; Stankova N; Jovchev J; Deliyski T; Stanilova S
Khirurgiia (Sofiia); 2010; (4-5):26-9. PubMed ID: 21972680
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives.
Adamo V; Franchina T; Minciullo PL; Pace E; Colonese F; Ricciardi GR; Saitta S; Ferraro M; Spatari G; Gangemi S
J Cell Physiol; 2011 Nov; 226(11):3032-4. PubMed ID: 21302302
[TBL] [Abstract][Full Text] [Related]
9. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production.
O'Hara RJ; Greenman J; MacDonald AW; Gaskell KM; Topping KP; Duthie GS; Kerin MJ; Lee PW; Monson JR
Clin Cancer Res; 1998 Aug; 4(8):1943-8. PubMed ID: 9717823
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies.
De Vita F; Orditura M; Galizia G; Romano C; Infusino S; Auriemma A; Lieto E; Catalano G
Cancer; 1999 Nov; 86(10):1936-43. PubMed ID: 10570416
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of preoperative serum levels of IL-12p40 and IL-23 for survival of patients with colorectal cancer.
Stanilov N; Miteva L; Jovchev J; Cirovski G; Stanilova S
APMIS; 2014 Dec; 122(12):1223-9. PubMed ID: 24909386
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
[TBL] [Abstract][Full Text] [Related]
13. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.
Nikiteas NI; Tzanakis N; Gazouli M; Rallis G; Daniilidis K; Theodoropoulos G; Kostakis A; Peros G
World J Gastroenterol; 2005 Mar; 11(11):1639-43. PubMed ID: 15786541
[TBL] [Abstract][Full Text] [Related]
14. [The levels of selected cytokines in patients with colorectal cancer--a preliminary report].
Grotowski M; Piechota W
Pol Merkur Lekarski; 2001 Oct; 11(64):327-9. PubMed ID: 11770312
[TBL] [Abstract][Full Text] [Related]
15. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
16. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
Johdi NA; Mazlan L; Sagap I; Jamal R
Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
[TBL] [Abstract][Full Text] [Related]
17. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
18. IL-22 promotes the proliferation of cancer cells in smoking colorectal cancer patients.
Song B; Ma Y; Liu X; Li W; Zhang J; Liu J; Han J
Tumour Biol; 2016 Jan; 37(1):1349-56. PubMed ID: 26293897
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
20. Circulating midkine in malignant and non-malignant colorectal diseases.
Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]